Brentuximab Vedotin Combo Active in Older Patients With Hodgkin Lymphoma

Sequential dosing of brentuximab vedotin before and after standard doxorubicin, vinblastine, and dacarbazine showed a survival benefit in a phase II trial.

from Latest articles from Cancer Therapy Advisor News https://ift.tt/2Q28FjU